Literature DB >> 8598649

Benign tyrosinaemia: an 18-year follow-up.

G Stoppoloni1, R Santinelli, F Prisco, G Canino, D Iafusco, F Di Palma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8598649     DOI： 10.1007/bf02436013

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.

Authors:  O Giardini; A Cantani; N G Kennaway; P D'Eufemia
Journal:  Pediatr Res       Date:  1983-01       Impact factor: 3.756

2.  A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.

Authors:  F Endo; H Katoh; S Yamamoto; I Matsuda
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

3.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  S Lindstedt; E Holme; E A Lock; O Hjalmarson; B Strandvik
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

4.  Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.

Authors:  F Endo; A Kitano; I Uehara; N Nagata; I Matsuda; T Shinka; T Kuhara; I Matsumoto
Journal:  Pediatr Res       Date:  1983-02       Impact factor: 3.756
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.